Literature DB >> 2318935

The effects of the menopause on calcitriol and parathyroid hormone: responses to a low dietary calcium stress test.

R L Prince1, I Dick, P Garcia-Webb, R W Retallack.   

Abstract

Calcium, calcitriol and PTH levels were studied in 11 premenopausal women, aged 41 +/- 3 yr (mean +/- SD), and 11 postmenopausal women, aged 42 +/- 3 yr, at baseline and in 9 women from each group during a 4-day low calcium diet. Serum dialyzable calcium and urinary hydroxyproline excretion were higher in the postmenopausal women at baseline and throughout the low calcium diet. Baseline calcitriol levels were significantly lower in the postmenopausal women, but these were associated with lower vitamin D-binding protein levels; the calculated free calcitriol index was not different between the two groups. After the low calcium diet calcitriol levels rose in both groups to similar levels. PTH levels were not different in the two groups at baseline and rose to the same level on the low calcium diet. These data indicate that estrogen deficiency at the menopause is not associated with deficient calcitriol or PTH reserve, although basal calcitriol levels may be reduced secondarily due to lower vitamin D-binding protein levels or relative hypercalcaemia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2318935     DOI: 10.1210/jcem-70-4-1119

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  The effects of menopause and estrogen replacement therapy on the renal handling of calcium.

Authors:  S Adami; D Gatti; F Bertoldo; M Rossini; A Fratta-Pasini; N Zamberlan; E Facci; V Lo Cascio
Journal:  Osteoporos Int       Date:  1992-07       Impact factor: 4.507

Review 2.  The calcium controversy.

Authors:  B E Nordin
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

3.  Oestrogen effects on calcium membrane transport: a new view of the inter-relationship between oestrogen deficiency and age-related osteoporosis.

Authors:  R L Prince; I Dick
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

4.  Calcium supplements controversy in osteoporosis: a physiological mechanism supporting cardiovascular adverse effects.

Authors:  Karolina Paziana; Michael Pazianas
Journal:  Endocrine       Date:  2015-02-17       Impact factor: 3.633

5.  Does estrogen replacement therapy influence parathyroid hormone responsiveness to exogenous hypercalcemia in postmenopausal women?

Authors:  I Zofková; S Röjdmark; R L Kancheva
Journal:  J Endocrinol Invest       Date:  1993-05       Impact factor: 4.256

6.  Differential effects of dietary calcium augmentation and hormone replacement therapy on bone turnover and serum levels of calcitrophic hormones.

Authors:  J F Aloia; A Vaswani; J K Yeh; L Russo
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.